<DOC>
	<DOCNO>NCT02885948</DOCNO>
	<brief_summary>This investigator lead , randomise , double blind , placebo control , double arm comparator study .</brief_summary>
	<brief_title>The Use Low Dose Prophylactic Naloxone Infusion Prevent Respiratory Depression With Intrathecal Morphine .</brief_title>
	<detailed_description>Delayed respiratory depression well-documented side effect associate use intrathecal morphine . This respiratory depression implication patient safety necessitates either observation patient high dependency set least 24 hour use alternative analgesic technique . Other associated side effect include pruritus , nausea vomit sedation . Naloxone effective treatment side effect . However , usually give reactive treatment side effect present . The hypothesis patient commence naloxone infusion low dose early injection intrathecal morphine clinically significant reduction incidence side effect . The primary endpoint reduction respiratory depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Subjects must age 18 year baseline Diagnosed hepatobiliary condition require elective major surgical resection general anaesthetic . Subjects must able willing give write informed consent comply requirement study protocol Allergy/sensitivity naloxone Female subject pregnant breastfeeding . Subjects receive investigational agent within 2 month Subjects take anticonvulsant medication epilepsy Subjects cardiac arrhythmia uncontrolled rate Subjects history chronic opioid use / chronic pain Any contraindication intrathecal injection eg coagulopathy Documented history obstructive sleep apnoea Treating clinician feel patient best interest randomise</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>